Rigel Pharmaceuticals, Inc. (RIGL) Social Stream



Rigel Pharmaceuticals, Inc. (RIGL): $3.90

0.07 (+1.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Rigel Pharmaceuticals Inc (RIGL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RIGL.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $11 $7 $8.33 $3.84 116.93%

The Trend in the Analyst Price Target


Over the past 126 days, RIGL's average price target has gone down $0.17.

RIGL reports an average of 123.31% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-11 6 11 7 8.33 3.87 115.25%
2021-09-04 6 11 7 8.33 4.05 105.68%
2021-08-28 6 11 7 8.33 3.83 117.49%
2021-08-14 6 11 7 8.50 3.72 128.49%
2021-08-07 6 11 7 8.50 3.81 123.1%
2021-08-05 6 11 7 8.50 3.89 118.51%
2021-08-01 6 11 7 8.50 4.00 112.5%
2021-07-24 6 11 7 8.50 4.12 106.31%
2021-07-17 6 11 7 8.50 4.06 109.36%
2021-07-10 6 11 7 8.50 4.31 97.22%
2021-07-03 6 11 7 8.50 4.41 92.74%
2021-06-26 6 11 7 8.50 4.54 87.22%
2021-06-13 6 11 7 8.50 4.02 111.44%
2021-06-05 6 11 7 8.50 3.98 113.57%
2021-05-22 6 11 7 8.50 3.65 132.88%
2021-05-15 6 11 7 8.50 3.71 129.11%
2021-05-08 6 11 7 8.50 3.38 151.48%
2021-04-25 6 11 7 8.50 3.65 132.88%
2021-04-17 6 11 7 8.50 3.58 137.43%
2021-04-10 6 11 7 8.50 3.26 160.74%
2021-04-03 6 11 7 8.50 3.43 147.81%
2021-03-20 6 11 7 8.50 3.99 113.03%
2021-03-13 6 11 7 8.50 4.23 100.95%
2021-03-06 6 11 7 8.50 3.84 121.35%
2021-02-27 6 11 7 8.50 4.15 104.82%
2020-12-18 6 8 5 7.33 3.74 95.99%
2020-12-09 6 8 5 7.33 3.12 134.94%
2020-12-07 6 8 5 7.33 3.02 142.72%
2020-11-06 6 8 5 7.33 2.62 179.77%
2020-10-19 7 8 5 7.14 2.60 174.62%
2020-08-09 7 8 5 7.14 NA NA%
2020-08-05 7 8 5 7.14 NA NA%
2020-07-20 7 8 5 7.00 NA NA%
2020-05-26 7 8 5 7.00 NA NA%

RIGL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 2 4 0 0 0 6

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The average analyst price target of RIGL is higher than 15.41% of all US stocks.
  • RIGL has a higher upside potential (average analyst target price relative to current price) than 84.01% of all US stocks.
  • The number of analysts covering the stock of RIGL is greater than 79.5% of stocks in the small market cap category.
  • The variance in analysts' estimates of RIGL is lower than 22.24% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Rigel Pharmaceuticals Inc are MDWD, CTIC and CDXC.

Is RIGL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7269 seconds.